5fmh
From Proteopedia
(Difference between revisions)
m (Protected "5fmh" [edit=sysop:move=sysop]) |
|||
Line 1: | Line 1: | ||
- | '''Unreleased structure''' | ||
- | + | ==Crystal structure of the E405K mutant of human apoptosis inducing factor== | |
- | + | <StructureSection load='5fmh' size='340' side='right' caption='[[5fmh]], [[Resolution|resolution]] 1.80Å' scene=''> | |
- | + | == Structural highlights == | |
- | + | <table><tr><td colspan='2'>[[5fmh]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5FMH OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5FMH FirstGlance]. <br> | |
- | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=FAD:FLAVIN-ADENINE+DINUCLEOTIDE'>FAD</scene></td></tr> | |
- | [[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5fmh FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5fmh OCA], [http://pdbe.org/5fmh PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5fmh RCSB], [http://www.ebi.ac.uk/pdbsum/5fmh PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5fmh ProSAT]</span></td></tr> |
+ | </table> | ||
+ | == Disease == | ||
+ | [[http://www.uniprot.org/uniprot/AIFM1_HUMAN AIFM1_HUMAN]] Defects in AIFM1 are the cause of combined oxidative phosphorylation deficiency type 6 (COXPD6) [MIM:[http://omim.org/entry/300816 300816]]. It is a mitochondrial disease resulting in a neurodegenerative disorder characterized by psychomotor delay, hypotonia, areflexia, muscle weakness and wasting.<ref>PMID:20362274</ref> <ref>PMID:22019070</ref> | ||
+ | == Function == | ||
+ | [[http://www.uniprot.org/uniprot/AIFM1_HUMAN AIFM1_HUMAN]] Probable oxidoreductase that has a dual role in controlling cellular life and death; during apoptosis, it is translocated from the mitochondria to the nucleus to function as a proapoptotic factor in a caspase-independent pathway, while in normal mitochondria, it functions as an antiapoptotic factor via its oxidoreductase activity. The soluble form (AIFsol) found in the nucleus induces 'parthanatos' i.e. caspase-independent fragmentation of chromosomal DNA. Interacts with EIF3G,and thereby inhibits the EIF3 machinery and protein synthesis, and activates casapse-7 to amplify apoptosis. Plays a critical role in caspase-independent, pyknotic cell death in hydrogen peroxide-exposed cells. Binds to DNA in a sequence-independent manner.<ref>PMID:17094969</ref> <ref>PMID:19418225</ref> <ref>PMID:20362274</ref> | ||
+ | == References == | ||
+ | <references/> | ||
+ | __TOC__ | ||
+ | </StructureSection> | ||
[[Category: Sevrioukova, I]] | [[Category: Sevrioukova, I]] | ||
+ | [[Category: Apoptosis]] | ||
+ | [[Category: Apoptosis inducing factor]] | ||
+ | [[Category: Flavoprotein]] | ||
+ | [[Category: Mitochiondria]] | ||
+ | [[Category: Oxidoreductase]] |
Revision as of 10:50, 10 December 2016
Crystal structure of the E405K mutant of human apoptosis inducing factor
|